CN102741409A - 等位基因梯基因座 - Google Patents
等位基因梯基因座 Download PDFInfo
- Publication number
- CN102741409A CN102741409A CN2010800623252A CN201080062325A CN102741409A CN 102741409 A CN102741409 A CN 102741409A CN 2010800623252 A CN2010800623252 A CN 2010800623252A CN 201080062325 A CN201080062325 A CN 201080062325A CN 102741409 A CN102741409 A CN 102741409A
- Authority
- CN
- China
- Prior art keywords
- allelotrope
- sample
- ladder
- locus
- test kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims abstract description 82
- 108091092878 Microsatellite Proteins 0.000 claims abstract description 15
- 108700028369 Alleles Proteins 0.000 claims abstract description 7
- 239000000523 sample Substances 0.000 claims description 73
- 150000007523 nucleic acids Chemical class 0.000 claims description 69
- 102000039446 nucleic acids Human genes 0.000 claims description 67
- 108020004707 nucleic acids Proteins 0.000 claims description 67
- 230000003321 amplification Effects 0.000 claims description 43
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 43
- 238000012360 testing method Methods 0.000 claims description 42
- 210000004027 cell Anatomy 0.000 claims description 41
- 238000003752 polymerase chain reaction Methods 0.000 claims description 35
- 239000003795 chemical substances by application Substances 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 210000004381 amniotic fluid Anatomy 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 14
- 241000768494 Polymorphum Species 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 13
- 239000008280 blood Substances 0.000 claims description 13
- 238000001962 electrophoresis Methods 0.000 claims description 11
- 239000002689 soil Substances 0.000 claims description 10
- 238000012408 PCR amplification Methods 0.000 claims description 9
- 210000000988 bone and bone Anatomy 0.000 claims description 9
- 210000004209 hair Anatomy 0.000 claims description 9
- 210000003296 saliva Anatomy 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 210000003491 skin Anatomy 0.000 claims description 9
- 210000001519 tissue Anatomy 0.000 claims description 9
- 210000000515 tooth Anatomy 0.000 claims description 9
- 210000003467 cheek Anatomy 0.000 claims description 8
- 230000001605 fetal effect Effects 0.000 claims description 8
- 210000000214 mouth Anatomy 0.000 claims description 8
- 210000002826 placenta Anatomy 0.000 claims description 8
- 210000002700 urine Anatomy 0.000 claims description 8
- 239000013074 reference sample Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 238000003556 assay Methods 0.000 abstract 1
- 238000003205 genotyping method Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 66
- 108091093088 Amplicon Proteins 0.000 description 31
- 125000003729 nucleotide group Chemical group 0.000 description 24
- 239000002773 nucleotide Substances 0.000 description 22
- 108091033319 polynucleotide Proteins 0.000 description 19
- 102000040430 polynucleotide Human genes 0.000 description 19
- 239000002157 polynucleotide Substances 0.000 description 19
- 238000005516 engineering process Methods 0.000 description 13
- 230000037230 mobility Effects 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102100040870 Glycine amidinotransferase, mitochondrial Human genes 0.000 description 4
- 101000893303 Homo sapiens Glycine amidinotransferase, mitochondrial Proteins 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000003415 peat Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091035286 Strbase Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960003311 ampicillin trihydrate Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005382 thermal cycling Methods 0.000 description 2
- 238000012056 up-stream process Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- WKKCYLSCLQVWFD-UHFFFAOYSA-N 1,2-dihydropyrimidin-4-amine Chemical compound N=C1NCNC=C1 WKKCYLSCLQVWFD-UHFFFAOYSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 240000006487 Aciphylla squarrosa Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 229940109357 desoxyribonuclease Drugs 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- CAEMOCUMMOVWCN-UHFFFAOYSA-N diphosphono hydrogen phosphate phosphoric acid Chemical compound OP(O)(O)=O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O CAEMOCUMMOVWCN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- -1 methane amide Chemical class 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008775 paternal effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000012340 reverse transcriptase PCR Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26445509P | 2009-11-25 | 2009-11-25 | |
| US61/264455 | 2009-11-25 | ||
| PCT/US2010/058111 WO2011066467A2 (en) | 2009-11-25 | 2010-11-24 | Allelic ladder loci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102741409A true CN102741409A (zh) | 2012-10-17 |
Family
ID=44067248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010800623252A Pending CN102741409A (zh) | 2009-11-25 | 2010-11-24 | 等位基因梯基因座 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8409806B2 (https=) |
| EP (1) | EP2504433B1 (https=) |
| JP (2) | JP2013511989A (https=) |
| CN (1) | CN102741409A (https=) |
| WO (1) | WO2011066467A2 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107012202A (zh) * | 2016-01-27 | 2017-08-04 | 希森美康株式会社 | 核酸扩增的精度管理方法、精度管理用试剂及其试剂盒 |
| CN109564189A (zh) * | 2016-12-09 | 2019-04-02 | 尹特根埃克斯有限公司 | 电泳图谱分析 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2504433B1 (en) | 2009-11-25 | 2014-10-29 | Life Technologies Corporation | Allelic ladder loci |
| US9556482B2 (en) | 2013-07-03 | 2017-01-31 | The United States Of America, As Represented By The Secretary Of Commerce | Mouse cell line authentication |
| AU2015311677A1 (en) * | 2014-09-05 | 2017-04-27 | Nantomics, Llc | Systems and methods for determination of provenance |
| EP3732216B1 (en) | 2017-12-26 | 2023-04-19 | Dow Global Technologies LLC | Process for the production of multimodal ethylene-based polymers |
| EP3732215B8 (en) * | 2017-12-26 | 2022-04-27 | Dow Global Technologies LLC | Dual reactor solution process for the production of multimodal ethylene-based polymer |
| WO2021018802A1 (en) * | 2019-07-26 | 2021-02-04 | Ark-Biodiversity Gmbh | Method for genetic profiling |
| US20250154577A1 (en) * | 2021-12-17 | 2025-05-15 | Life Technologies Corporation | Compositions, kits, and methods for short tandem repeat analysis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599666A (en) * | 1994-03-28 | 1997-02-04 | Promega Corporation | Allelic ladders for short tandem repeat loci |
| EP0887426A2 (en) * | 1997-06-28 | 1998-12-30 | The Secretary of State for the Home Department | Improvement in and relating to forensic identification |
| CN101225386A (zh) * | 2008-01-22 | 2008-07-23 | 西安交通大学 | 一种新的10个y染色体短串联重复序列位点及其分型方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994064A (en) | 1996-04-24 | 1999-11-30 | Identigene, Inc. | Simple and complex tandem repeats with DNA typing method |
| US6156512A (en) | 1996-05-23 | 2000-12-05 | Promega Corp | Allelic ladders for short tandem repeat loci |
| AT503721A1 (de) * | 2006-06-01 | 2007-12-15 | Forsch Krebskranke Kinder | Alleldetektion |
| US20090004662A1 (en) * | 2007-06-18 | 2009-01-01 | Applera Corporation | Method and compositions for nucleic acid amplification |
| TW200930818A (en) * | 2007-10-30 | 2009-07-16 | Applied Biosystems | Method and kits for multiplex amplification of short tandem repeat loci |
| EP2504433B1 (en) * | 2009-11-25 | 2014-10-29 | Life Technologies Corporation | Allelic ladder loci |
-
2010
- 2010-11-24 EP EP10833985.4A patent/EP2504433B1/en not_active Not-in-force
- 2010-11-24 US US12/954,551 patent/US8409806B2/en active Active
- 2010-11-24 CN CN2010800623252A patent/CN102741409A/zh active Pending
- 2010-11-24 WO PCT/US2010/058111 patent/WO2011066467A2/en not_active Ceased
- 2010-11-24 JP JP2012541209A patent/JP2013511989A/ja not_active Withdrawn
-
2016
- 2016-01-28 JP JP2016014005A patent/JP6100933B2/ja active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599666A (en) * | 1994-03-28 | 1997-02-04 | Promega Corporation | Allelic ladders for short tandem repeat loci |
| EP0887426A2 (en) * | 1997-06-28 | 1998-12-30 | The Secretary of State for the Home Department | Improvement in and relating to forensic identification |
| CN101225386A (zh) * | 2008-01-22 | 2008-07-23 | 西安交通大学 | 一种新的10个y染色体短串联重复序列位点及其分型方法 |
Non-Patent Citations (1)
| Title |
|---|
| 白雪等: "西北汉族人群D10S1248、D2S441、D1S1677、D9S1122、D10S1435等5个miniSTR基因座的遗传多态性及其法医学应用", 《遗传》, vol. 31, no. 04, 30 April 2009 (2009-04-30) * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107012202A (zh) * | 2016-01-27 | 2017-08-04 | 希森美康株式会社 | 核酸扩增的精度管理方法、精度管理用试剂及其试剂盒 |
| CN107012202B (zh) * | 2016-01-27 | 2021-11-19 | 希森美康株式会社 | 核酸扩增的精度管理方法、精度管理用试剂及其试剂盒 |
| CN109564189A (zh) * | 2016-12-09 | 2019-04-02 | 尹特根埃克斯有限公司 | 电泳图谱分析 |
| CN109564189B (zh) * | 2016-12-09 | 2023-09-19 | 尹特根埃克斯有限公司 | 电泳图谱分析 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20110171654A1 (en) | 2011-07-14 |
| WO2011066467A3 (en) | 2011-10-27 |
| JP2016063833A (ja) | 2016-04-28 |
| EP2504433B1 (en) | 2014-10-29 |
| JP6100933B2 (ja) | 2017-03-22 |
| EP2504433A4 (en) | 2013-06-19 |
| EP2504433A2 (en) | 2012-10-03 |
| US8409806B2 (en) | 2013-04-02 |
| WO2011066467A2 (en) | 2011-06-03 |
| JP2013511989A (ja) | 2013-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102741409A (zh) | 等位基因梯基因座 | |
| US10704091B2 (en) | Genotyping by next-generation sequencing | |
| US8975019B2 (en) | Deducing exon connectivity by RNA-templated DNA ligation/sequencing | |
| US20140274811A1 (en) | Methods for Amplifying a Complete Genome or Transcriptome | |
| US20120028310A1 (en) | Isothermal nucleic acid amplification methods and compositions | |
| JP2020522243A (ja) | 核酸のマルチプレックス末端タギング増幅 | |
| WO2000031306A2 (en) | Multiplex amplification of short tandem repeat loci | |
| KR20070011354A (ko) | 취약 ｘ염색체 증후군과 같은 ｓｔｒｐ의 검출 방법 | |
| EP1585974A2 (en) | Methods of predicting mortality risk by determining telomere length | |
| US20190177760A1 (en) | Methods for Amplification of Nucleic Acids Utilizing Clamp Oligonucleotides | |
| US10202629B2 (en) | Methods for amplification of nucleic acids utilizing clamp oligonucleotides | |
| US9506113B2 (en) | Nucleic acid ligation systems and methods | |
| US20060166228A1 (en) | Markers of alterations in the Y chromosome and uses therefor | |
| US20050244830A1 (en) | Quantitative multiplex amplification on a genomic scale, and applications for detecting genomic rearrangements | |
| KR101843432B1 (ko) | 소 미토콘드리아 dna의 단일염기다형성 마커를 포함하는 소 개체 및 품종 식별용 조성물, 및 이를 이용하는 소의 식별 방법 | |
| KR101700622B1 (ko) | 개의 품종 식별을 위한 dna 마커 및 이를 이용한 개 품종 식별방법 | |
| US10072290B2 (en) | Methods for amplifying fragmented target nucleic acids utilizing an assembler sequence | |
| AU2019346343B2 (en) | 5' adapter comprising an internal 5'-5' linkage | |
| CN108251531B (zh) | Ensg00000267549在判断骨肉瘤转移中的应用 | |
| CN109312397A (zh) | Penta E基因座多态性人体鉴定 | |
| Goldammer et al. | Targeted generation of 16 sequence-tagged sites for bovine chromosome region 5q21-q25 by microdissection | |
| JP2006158220A (ja) | マイコプラズマ・ニューモニエ（Ｍｙｃｏｐｌａｓｍａｐｎｅｕｍｏｎｉａｅ）検出のためのオリゴヌクレオチドプライマー | |
| Karere | Development of a high resolution whole genome radiation hybrid map for interrogating the rhesus macaque genome assembly | |
| HK1204337B (en) | Genotyping by next-generation sequencing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121017 |